Scinai Immunotherapeutics (SCNI) Total Liabilities (2016 - 2025)

Scinai Immunotherapeutics has disclosed Total Liabilities across 9 years of filings, most recently posting $19.6 billion for Q4 2025.

• Total Liabilities for Q4 2025 came in at $19.6 billion, up 563250.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.6 billion (up 563250.94% YoY), and the FY2025 annual result was $19.6 billion, up 563250.94% from the prior year.
• Total Liabilities came in at $19.6 billion for Q4 2025 at Scinai Immunotherapeutics, up from $4.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $19.6 billion in Q4 2025 to a low of -$722.7 million in Q2 2022.
• The 5-year median for Total Liabilities is $22.0 million (2023), against an average of $1.3 billion.
• Across the five-year window, Total Liabilities tumbled 89.39% in 2024 and soared 563250.94% in 2025, its largest moves.
• Scinai Immunotherapeutics' Total Liabilities stood at $31.1 million in 2021, then slipped by 7.17% to $28.8 million in 2022, then fell by 23.54% to $22.0 million in 2023, then tumbled by 84.25% to $3.5 million in 2024, then jumped by 563250.94% to $19.6 billion in 2025.
• The last three Total Liabilities figures came in at $19.6 billion (Q4 2025), $4.0 million (Q2 2025), and $3.5 million (Q4 2024), per Business Quant data.